Dr Agarwal's Health [AGARWALEYE] vs Prevest Denpro [PREVEST] Detailed Stock Comparison

Dr Agarwal's Health

NSE
Loading...

Prevest Denpro

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Dr Agarwal's Health wins in 5 metrics, Prevest Denpro wins in 12 metrics, with 0 ties. Prevest Denpro appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricDr Agarwal's HealthPrevest DenproBetter
P/E Ratio (TTM)156.1334.61Prevest Denpro
Price-to-Book Ratio8.456.19Prevest Denpro
Debt-to-Equity Ratio49.870.00Prevest Denpro
PEG RatioN/A1.74N/A
EV/EBITDA39.6725.53Prevest Denpro
Profit Margin (TTM)5.66%28.86%Prevest Denpro
Operating Margin (TTM)13.32%30.58%Prevest Denpro
EBITDA Margin (TTM)13.32%30.58%Prevest Denpro
Return on Equity4.33%17.20%Prevest Denpro
Return on Assets (TTM)2.27%16.13%Prevest Denpro
Free Cash Flow (TTM)$394.30M$128.49MDr Agarwal's Health
Dividend YieldN/A0.17%N/A
1-Year Return21.97%-8.47%Dr Agarwal's Health
Price-to-Sales Ratio (TTM)8.809.99Dr Agarwal's Health
Enterprise Value$162.90B$5.88BDr Agarwal's Health
EV/Revenue Ratio9.088.99Prevest Denpro
Gross Profit Margin (TTM)43.48%77.43%Prevest Denpro
Revenue per Share (TTM)$58$55Dr Agarwal's Health
Earnings per Share (Diluted)$3.20$15.73Prevest Denpro
Beta (Stock Volatility)N/A0.43N/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Dr Agarwal's Health vs Prevest Denpro Stock Performance Analysis

Loading Price Chart...

Dr Agarwal's Health
Prevest Denpro
Dr Agarwal's Health Stock Overview | Prevest Denpro Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Dr Agarwal's Health3.18%-1.67%14.06%15.16%17.52%22.10%
Prevest Denpro-0.85%-0.61%-2.93%-6.29%12.17%-10.00%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Dr Agarwal's Health21.97%21.97%21.97%21.97%21.97%21.97%
Prevest Denpro-8.47%36.54%103.77%103.77%103.77%103.77%

News Based Sentiment: Dr Agarwal's Health vs Prevest Denpro

Dr Agarwal's Health

News based Sentiment: MIXED

October saw a slight stock price decrease alongside continued consideration for dividend portfolios, creating a mixed investment narrative. The company's dividend yield and market capitalization remain key factors for investors, but the recent price decline warrants attention.

View Dr Agarwal's Health News Sentiment Analysis

Prevest Denpro

News based Sentiment: MIXED

The month presented a mixed picture for Prevest Denpro, with both positive and negative developments. While asset growth and cash flow are encouraging, the decline in income and share price warrants caution. This makes October a moderately important month for investors tracking the company.

View Prevest Denpro News Sentiment Analysis

Performance & Financial Health Analysis: Dr Agarwal's Health vs Prevest Denpro

MetricAGARWALEYEPREVEST
Market Information
Market Cap i₹157.95B₹6.60B
Market Cap CategoryMid capSmall cap
10 Day Avg. Volume i415,1976,440
90 Day Avg. Volume i292,2079,273
Last Close₹506.00₹535.40
52 Week Range₹327.00 - ₹515.00₹393.60 - ₹686.00
% from 52W High-1.75%-21.95%
All-Time High₹515.00 (Oct 01, 2025)₹686.00 (Jan 13, 2025)
% from All-Time High-1.75%-21.95%
Growth Metrics
Quarterly Revenue Growth0.21%0.18%
Quarterly Earnings Growth1.51%0.20%
Financial Health
Profit Margin (TTM) i0.06%0.29%
Operating Margin (TTM) i0.13%0.31%
Return on Equity (TTM) i0.04%0.17%
Debt to Equity (MRQ) i49.870.00
Cash & Liquidity
Book Value per Share (MRQ)₹59.09₹87.89
Cash per Share (MRQ)₹16.23₹54.65
Operating Cash Flow (TTM) i₹1.43B₹185.37M
Levered Free Cash Flow (TTM) i₹834.60M₹181.55M
Dividends
Last 12-Month Dividend Yield iN/A0.17%
Last 12-Month Dividend iN/A₹1.00

Valuation & Enterprise Metrics Analysis: Dr Agarwal's Health vs Prevest Denpro

MetricAGARWALEYEPREVEST
Price Ratios
P/E Ratio (TTM) i156.1334.61
Forward P/E i89.83N/A
PEG Ratio iN/A1.74
Price to Sales (TTM) i8.809.99
Price to Book (MRQ) i8.456.19
Market Capitalization
Market Capitalization i₹157.95B₹6.60B
Enterprise Value i₹162.90B₹5.88B
Enterprise Value Metrics
Enterprise to Revenue i9.088.99
Enterprise to EBITDA i39.6725.53
Risk & Other Metrics
Beta iN/A0.43
Book Value per Share (MRQ) i₹59.09₹87.89

Financial Statements Comparison: Dr Agarwal's Health vs Prevest Denpro

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)AGARWALEYEPREVEST
Revenue/Sales i₹4.87B₹157.66M
Cost of Goods Sold i₹2.75B₹35.59M
Gross Profit i₹2.12B₹122.08M
Research & Development iN/AN/A
Operating Income (EBIT) i₹649.10M₹48.22M
EBITDA i₹1.41B₹64.79M
Pre-Tax Income i₹536.00M₹59.88M
Income Tax i₹155.40M₹15.83M
Net Income (Profit) i₹380.60M₹44.05M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)AGARWALEYEPREVEST
Cash & Equivalents i₹1.04B₹608.98M
Total Current Assets i₹7.94B₹857.15M
Total Current Liabilities i₹4.78B₹59.62M
Long-Term Debt i₹8.08B₹0
Total Shareholders Equity i₹19.27B₹1.06B
Retained Earnings iN/A₹733.61M
Property, Plant & Equipment i₹13.40B₹13.99M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)AGARWALEYEPREVEST
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricAGARWALEYEPREVEST
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i415,1976,440
Average Daily Volume (90 Day) i292,2079,273
Shares Outstanding i315.88M12.00M
Float Shares i53.12M2.48M
% Held by Insiders i0.76%0.78%
% Held by Institutions i0.17%0.00%

Dividend Analysis & Yield Comparison: Dr Agarwal's Health vs Prevest Denpro

MetricAGARWALEYEPREVEST
Last 12-Month Dividend iN/A₹1.00
Last 12-Month Dividend Yield iN/A0.17%
3-Year Avg Annual Dividend iN/A₹0.33
3-Year Avg Dividend Yield iN/A0.17%
3-Year Total Dividends iN/A₹1.00
Ex-Dividend DateN/ASep 03, 2025